Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 1936 AL 1950

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities

Visanji NP, Lang AE, Kovacs GG.

Transl Neurodegener. 2019 Sep 4;8:28. doi: 10.1186/s40035-019-0172-x. eCollection 2019.

Deep brain stimulation and genetic variability in Parkinson's disease: a review of the literature

Ligaard J, Sannæs J, Pihlstrøm L.

NPJ Parkinsons Dis. 2019 Sep 6;5:18. doi: 10.1038/s41531-019-0091-7. eCollection 2019.

Advanced glycation end products (AGEs), protein aggregation and their cross talk: new insight in tumorigenesis

Haque E, Kamil M, Hasan A, Irfan S, Sheikh S, Khatoon A, Nazir A, Mir SS.

Glycobiology. 2019 Dec 12;30(1):49-57. doi: 10.1093/glycob/cwz073.

Parkinsonism and neurosarcoidosis: Cause and effect or coincidence?

Mehanna R, Stone L, Itin I.

Clin Park Relat Disord. 2019 Sep 12;1:74-76. doi: 10.1016/j.prdoa.2019.09.001. eCollection 2019.

Deep Brain Stimulation in Parkinson's Disease

Malek N.

Neurol India. 2019 Jul-Aug;67(4):968-978. doi: 10.4103/0028-3886.266268.

The role of G protein-coupled estrogen receptor 1 on neurological disorders

Roque C, Mendes-Oliveira J, Duarte-Chendo C, Baltazar G.

Front Neuroendocrinol. 2019 Oct;55:100786. doi: 10.1016/j.yfrne.2019.100786. Epub 2019 Sep 9.

Neurosteroids as regulators of neuroinflammation

Yilmaz C, Karali K, Fodelianaki G, Gravanis A, Chavakis T, Charalampopoulos I, Alexaki VI.

Front Neuroendocrinol. 2019 Oct;55:100788. doi: 10.1016/j.yfrne.2019.100788. Epub 2019 Sep 9.

Study protocol for a single-blind randomised controlled trial to evaluate the clinical effects of an Integrated Qigong exercise intervention on freezing of gait in Parkinson's disease

Li Z, Zhuang J, Jiang Y, Xiao G, Jie K, Wang T, Yin W, Zhang Y, Wang Z.

BMJ Open. 2019 Sep 12;9(9):e028869. doi: 10.1136/bmjopen-2018-028869.

Challenging arrhythmias in a Wolff-Parkinson-White patient: Different physiology and adjacent troubles

Ali H, Foresti S, Mariucci E, Bronzetti G, De Ambroggi G, Cappato R.

J Cardiovasc Electrophysiol. 2019 Nov;30(11):2542-2545. doi: 10.1111/jce.14173. Epub 2019 Sep 25.

From medications to surgery: advances in the treatment of motor complications in Parkinson's disease

Nagao KJ, Patel NJ.

Drugs Context. 2019 Aug 13;8:212592. doi: 10.7573/dic.212592. eCollection 2019.

Targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of Parkinson's disease

Domingos S, Duarte T, Saraiva L, Guedes RC, Moreira R.

Future Med Chem. 2019 Aug;11(15):1953-1977. doi: 10.4155/fmc-2018-0484.

Cognitive and Behavioral Changes in Patients Treated With Droxidopa for Neurogenic Orthostatic Hypotension: A Retrospective Review

McDonell KE, Shibao CA, Biaggioni I, Hartman A, Robertson D, Claassen DO.

Cogn Behav Neurol. 2019 Sep;32(3):179-184. doi: 10.1097/WNN.0000000000000198.

Interindividual Balance Adaptations in Response to Perturbation Treadmill Training in Persons With Parkinson Disease

Klamroth S, Gaßner H, Winkler J, Eskofier B, Klucken J, Pfeifer K, Steib S.

J Neurol Phys Ther. 2019 Oct;43(4):224-232. doi: 10.1097/NPT.0000000000000291.

Association between the DRD2 TaqIA gene polymorphism and Parkinson disease risk: an updated meta-analysis

Yu M, Huang F, Wang W, Zhao C.

Medicine (Baltimore). 2019 Sep;98(37):e17136. doi: 10.1097/MD.0000000000017136.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias